Prenatal diagnosis
Pre-birth diagnostics is a system for testing of sicknesses before the conception of a tyke, to decide certain inheritable issue, for example, chromosome irregularities, Down's disorder, hereditary infections, neural tube deformities, and different conditions. It can be led by different systems of screening, regular testing, hereditary testing and different measures in instances of high hazard identified with the conception of a tyke.
Sometimes, the tests are directed to figure out whether the hatchling will be prematurely ended, however doctors and patients additionally think that its valuable to analyze high-hazard pregnancies early with the goal that conveyance can be booked in a tertiary consideration healing facility where the child can get suitable consideration.
There are three purposes of pre-birth analysis: (1) to empower auspicious medicinal or surgical treatment of a condition before or after conception, (2) to allow the folks to prematurely end a hatchling with the analyzed condition, and (3) to allow folks to "get ready" mentally, socially, monetarily, and therapeutically for an infant with a wellbeing issue or incapacity. Having this data ahead of time of the conception implies that medicinal services staff and in addition folks can better set themselves up for the conveyance of a kid with a wellbeing issue. For instance, Down disorder is connected with heart abandons that might require mediation quickly upon conception. Numerous hopeful folks might want to know the sex of their child before conception.
The worldwide business sector for pre-birth diagnostics in 2010 was USD 5.35 billion and it is relied upon to develop with a CAGR of 4.35% and create incomes of USD 5.89 billion by 2018.The U.S. is the business sector pioneer in pre-birth diagnostics took after by Europe. The business sector is relied upon to develop in the economies of Latin America and Asia Pacific. Central point driving the development of pre-birth diagnostics market incorporate expansion in recognition rates of Down's disorder, expanding interest for non intrusive pre-birth diagnostics, progression in innovations, furthermore because of expanding period of moms which upgrades the likelihood and danger of chromosomal variations from the norm.
Related Conference of Prenatal diagnosis
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Prenatal diagnosis Conference Speakers
Recommended Sessions
- Bioprocess Engineering and Biomarkers
- Cancer Genomics
- Chromosomal Abnormalities
- Clinical applications and diagnostics
- Cytogenetics
- Ecogenomics
- Evolution of Novel Genes
- Gene Expression, Regulation And Cloning
- Gene Mapping
- Genetic counseling
- Genetic Disorders Tests
- Genetic engineering techniques
- Genetic Testing Market
- Genetically modified organisms
- Genomic analysis
- Genomic data
- Genomic medicine
- Global DNA and Gene Chip (Microarrays)
- Medical genomics
- Microbial genetics
- Molecular Medicine
- Next generation sequencing
- Novel medical Devices
- Pedigree Methods
- Personalised genomics
- Pharmacogenetics
- Polygenic inheritance
- Prenatal diagnosis
- Reprogenetics
- Teratogenesis and their effects
- Tissue culture techniques
- Tissue Engineering and Regeneration
- Transgenic Research
- Tumor Markers
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)

